The popularity of Viagra initially drove a surge for major pharmaceutical companies, but recent developments present a complicated picture for shareholders. Lower-cost versions are reducing profits, and ongoing https://aprilozlk709025.blog2freedom.com/41284508/the-blue-pill-and-the-pharmaceutical-industry-a-volatile-bet